An Exploratory, Multi-centre, Double-blind, Placebocontrolled Crossover Study, to Investigate the Bronchodilatory Efficacy of a Single Dose of Indacaterol in Fixed Combination With Mometasone Furoate Delivered Via a MDDPI (Twisthaler) in Adult Patients With Persistent Asthma Using Open Label Seretide Accuhaler (50/250 Mcg b.i.d.) as an Active Control

Trial Profile

An Exploratory, Multi-centre, Double-blind, Placebocontrolled Crossover Study, to Investigate the Bronchodilatory Efficacy of a Single Dose of Indacaterol in Fixed Combination With Mometasone Furoate Delivered Via a MDDPI (Twisthaler) in Adult Patients With Persistent Asthma Using Open Label Seretide Accuhaler (50/250 Mcg b.i.d.) as an Active Control

Completed
Phase of Trial: Phase II

Latest Information Update: 05 May 2015

At a glance

  • Drugs Indacaterol/mometasone (Primary) ; Salmeterol/fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 03 Jul 2012 Additional locations (France, Germany) added as reported by European Clinical Trials Database.
    • 09 Jun 2008 Actual completion date (Apr 2008) added as reported by ClinicalTrials.gov.
    • 09 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top